Clinical trial / 2020
Resveratrol supplementation improved pain perception, somatic menopausal symptoms, and general well-being in healthy postmenopausal women.
In a 24-month randomized, double-blind, placebo-controlled crossover trial, 125 healthy postmenopausal women received resveratrol (75 mg twice daily) or placebo to assess effects on well-being and cerebrovascular function. Resveratrol supplementation significantly reduced composite pain score (P < 0.001), especially in overweight participants, and this reduction was associated with improved cerebrovascular responsiveness to hypercapnia (R = -0.329, P = 0.014). Somatic menopausal symptoms (P = 0.024) and general well-being (P = 0.010) were also improved.
- Study type
- Randomized, double-blind, placebo-controlled crossover trial
- Who was studied
- 125 healthy postmenopausal women
- What was measured
- Pain perception, mood/depressive symptoms, menopausal symptoms, sleep, quality of life, cerebrovascular responsiveness to hypercapnia
THE PAPER
Long-term resveratrol supplementation improves pain perception, menopausal symptoms, and overall well-being in postmenopausal women: findings from a 24-month randomized, controlled, crossover trial.
Thaung Zaw JJ, Howe PRC, Wong RHX. Menopause, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.